In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica
Abstract Introduction Leishmania aethiopica (L. aethiopica) is responsible for different forms of cutaneous leishmaniasis (CL) in Ethiopia. Treatment heavily depends on limited drugs, together with drawbacks like toxicity and microbial resistance. The current research aimed to investigate in vitro g...
Main Authors: | Markos Tadele, Solomon M. Abay, Peter Asaga, Eyasu Makonnen, Asrat Hailu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40360-021-00538-2 |
Similar Items
-
First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia
by: Gashaw Azanaw Amare, et al.
Published: (2023-12-01) -
Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
by: Tadele M, et al.
Published: (2020-03-01) -
In vitro Anti-Leishmanial Activities of Methanol Extract of Brucea antidysenterica J.F. Mill Seeds and Its Solvent Fractions
by: Ketema T, et al.
Published: (2023-03-01) -
Cutaneous leishmaniasis in cats (Felis domesticus) caused by Leishmania (Leishmania) venezuelensis
by: Rafael Bonfante Garrido, et al.
Published: (2010-07-01) -
Index to Studia Aethiopica
by: Verena Böll, et al.
Published: (2012-11-01)